LC–MS in the Development of Natural Product Based Antidiabetic Drugs: A Systematic Review
DOI:
https://doi.org/10.58511/v3i2.9692Kata Kunci:
LC-MS, Metabolomics, Natural Products, Antidiabetic, Type 2 Diabetes MellitusAbstrak
Natural products have great potential as a source for developing antidiabetic drugs, but matrix complexity and phytochemical variations are the main challenges in identifying bioactive compounds. This systematic literature review aims to evaluate the role of liquid chromatography–mass spectrometry (LC–MS) in the development of natural product-based antidiabetic drugs, particularly in type 2 diabetes mellitus (T2DM). The literature search was carried out following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines using the PubMed, Scopus, Web of Science, and ScienceDirect databases. The study results show that LC–MS plays an important role in comprehensive phytochemical profiling, high-confidence metabolite identification, and dereplication of complex natural matrices. Integration of LC–MS with metabolomics and pharmacology approaches provides a deeper mechanistic understanding of antidiabetic effects, including modulation of glucose and lipid metabolism. However, methodological heterogeneity between studies is still an obstacle, so protocol standardization and bioinformatics integration are needed to increase translational relevance towards clinical applications.
Referensi
[1] D. O. F. Diabetes, “Diagnosis and Classi fi cation of Diabetes Mellitus,” vol. 35, 2012, doi: 10.2337/dc12-s064.
[2] T. Karagiannis, P. Paschos, K. Paletas, D. R. Matthews, and A. Tsapas, “Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting : systematic review and meta-analysis,” vol. 1369, no. March, pp. 1–15, 2012, doi: 10.1136/bmj.e1369.
[3] A. Kengne et al., “Blood Pressure Variables and Cardiovascular Risk,” pp. 399–404, 2009, doi: 10.1161/HYPERTENSIONAHA.109.133041.
[4] A. S. Habib Yaribeygi, Stephen L. Atkin, “Natural compounds with DPP-4 inhibitory effects: Implications for the treatment of diabetes,” J. Cell. Biochem., vol. Volume120, no. 7, pp. 10909–10913, 2019, doi: https://doi.org/10.1002/jcb.28467.
[5] H. Yaribeygi and S. L. Atkin, “Natural compounds with DPP ‐ 4 inhibitory effects : Implications for the treatment of diabetes,” no. October 2018, pp. 1–5, 2019, doi: 10.1002/jcb.28467.
[6] Y. Gao et al., “Recent Progress in Natural Products as DPP-4 Inhibitors,” Future Med. Chem., vol. 7, no. 8, pp. 1079–1089, 2015, doi: https://doi.org/10.4155/fmc.15.49.
[7] M. Hasanpour, M. Iranshahy, and M. Iranshahi, “Biomedicine & Pharmacotherapy The application of metabolomics in investigating anti-diabetic activity of medicinal plants,” Biomed. Pharmacother., vol. 128, no. May, p. 110263, 2020, doi: 10.1016/j.biopha.2020.110263.
[8] E. Butt et al., “Food Chemistry : X Guava ( Psidium guajava ): A brief overview of its therapeutic and health potential ☆,” Food Chem. X, vol. 31, no. September 2024, p. 103027, 2025, doi: 10.1016/j.fochx.2025.103027.
[9] S. Chu, F. Zhang, H. Wang, L. Xie, Z. Chen, and W. Zeng, “Aqueous Extract of Guava ( Psidium guajava L .) Leaf Ameliorates Hyperglycemia by Promoting Hepatic Glycogen Synthesis and Modulating Gut Microbiota,” vol. 13, no. June, pp. 1–13, 2022, doi: 10.3389/fphar.2022.907702.
[10] A. J. Tradit et al., “EXTRACTION , ISOLATION AND CHARACTERIZATION OF BIOACTIVE COMPOUNDS FROM PLANTS ’ EXTRACTS Institute for Research in Molecular Medicine ( INFORM ), Universiti Sains Malaysia , Minden 11800 ,” vol. 8, pp. 1–10, 2011.
[11] W. M. A. Niessen, Liquid Chromatography— Mass Spectrometry. 2017.
[12] B. Warwick et al., “Mass appeal Mass appeal : metabolite identification in mass spectrometry-focused untargeted metabolomics,” 2025, doi: 10.1007/s11306-012-0434-4.
[13] C. W. K. G. Y. G. Y. Xu, “Plasma Phospholipid Metabolic Profiling and Biomarkers of Type 2 Diabetes Mellitus Based on High-Performance Liquid Chromatography/Electrospray Mass Spectrometry and Multivariate Statistical Analysis,” Anal. Chem., vol. 77, no. 13, doi: https://pubs.acs.org/doi/10.1021/ac0481001.
[14] J. Liu, L. Bai, W. Wang, Y. Song, W. Zhao, and Q. Li, “LC-MS-Based Lipidomic Analysis of Serum Samples from Patients with Type 2 Diabetes Mellitus ( T2DM ),” vol. 2022, 2022.
[15] W. Ji, X. Xie, and D. Qiang, “Molecular Omics metabolism in the progression of pre-diabetes to,” pp. 333–347, 2024, doi: 10.1039/d3mo00130j.
[16] X. W. Aihua Zhang, Hui Sun, “Mass spectrometry-driven drug discovery for development of herbal medicine,” vol. 37, no. 3, pp. 307–320, 2016, doi: https://doi.org/10.1002/mas.21529.
[17] M. S. Metabolomics, “NIH Public Access,” vol. 26, no. 1, pp. 51–78, 2007.
[18] Q. Guerrero et al., “Metabolomics in Ecology and Bioactive Natural Products Discovery : Challenges and Prospects for a Comprehensive Study of the Specialised Metabolome,” vol. 76, 2022, doi: 10.2533/chimia.2022.954.
[19] M. C. O. and C. J. C. Chukwuebuka Egbuna*, Chinaza G. Awuchi, Garima Kushwaha, Mithun Rudrapal, Kingsley C. Patrick-Iwuanyanwu, Omkar Singh, Uchenna E. Odoh, Johra Khan, Jaison Jeevanandam, Suresh Kumarasamy, Vincent O. Chukwube, Mathiyazhagan Narayanan, Santwana Palai, Mihnea, “Bioactive Compounds Effective Against Type 2 Diabetes Mellitus: A Systematic Review,” vol. 21, no. 12, pp. 1067–1095, 2021, doi: 10.2174/1568026621666210509161059.
[20] N. Tran, B. Pham, and L. Le, “Bioactive Compounds in Anti-Diabetic Plants :,” no. Dm, 2020.
[21] J. A. Chahrour, Z. A. Baki, D. El Badan, G. Nasser, M. Maresca, and A. Hijazi, “Herbal Medicines in the Management of Diabetes Mellitus : Plants , Bioactive Compounds , and Mechanisms of Action,” pp. 1–28, 2025.
[22] M. A. Brishti, F. V. Francis, and M. D. Leo, “Plasma Metabolomic Profiling Reveals Systemic Alterations in a Mouse Model of Type 2 Diabetes,” pp. 1–18, 2025.
[23] F. Zhang, S. Shan, C. Fu, S. Guo, C. Liu, and S. Wang, “Advanced Mass Spectrometry-Based Biomarker Identification for Metabolomics of Diabetes Mellitus and Its Complications,” pp. 1–29, 2024.
[24] Y. Ismail, D. M. Fahmy, and M. H. Ghattas, “Integrating experimental model , LC-MS / MS chemical analysis , and systems biology approach to investigate the possible antidiabetic effect and mechanisms of Matricaria aurea ( Golden Chamomile ) in type 2 diabetes mellitus,” no. September, pp. 1–28, 2022, doi: 10.3389/fphar.2022.924478.
[25] S. Banerjee, W. Jaidee, N. Rujanapun, and T. Duangyod, “Network pharmacology and metabolomics reveal mathurameha , a Thai traditional Anti-Diabetic formula , enhances glucose metabolism through PI3K-AKT / AMPK / GLUT4 pathway modulation,” pp. 1–20, 2025.
[26] N. P. Long, T. D. Nghi, Y. P. Kang, and N. H. Anh, “Toward a Standardized Strategy of Clinical Metabolomics for the Advancement of Precision Medicine,” pp. 1–28, 2018.
[27] A. Manuscript, “NIH Public Access,” vol. 13, no. 4, pp. 263–269, 2013, doi: 10.1038/nrm3314.Metabolomics.
[28] C. Of and M. In, “Metabolomics and Diabetes : Analytical and Computational Approaches,” vol. 64, no. September 2014, pp. 718–732, 2015, doi: 10.2337/db14-0509.
[29] Q. Jin, Metabolomics in Diabetes and Diabetic Complications : Insights from Epidemiological Studies. 2021.
